Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring
- PMID: 33912711
- PMCID: PMC8066425
- DOI: 10.1016/j.heliyon.2021.e06730
Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring
Abstract
Cannabis is the most commonly used illicit drug worldwide. Recently, cannabis use among young pregnant women has greatly increased. However, prenatal cannabinoid exposure leads to long-lasting cognitive, motor, and behavioral deficits in the offspring and alterations in neural circuitry through various mechanisms. Although these effects have been studied in the hippocampus, the effects of prenatal cannabinoid exposure on the cerebellum are not well elucidated. The cerebellum plays an important role in balance and motor control, as well as cognitive functions such as attention, language, and procedural memories. The aim of this study was to investigate the effects of prenatal cannabinoid exposure on the cerebellum of adolescent offspring. Pregnant rats were treated with synthetic cannabinoid agonist WIN55,212-2, and the offspring were evaluated for various cerebellar markers of oxidative stress, mitochondrial function, and apoptosis. Additionally, signaling proteins associated with glutamate dependent synaptic plasticity were examined. Administration of WIN55,212-2 during pregnancy altered markers of oxidative stress by significantly reducing oxidative stress and nitrite content. Mitochondrial Complex I and Complex IV activities were also enhanced following prenatal cannabinoid exposure. With regard to apoptosis, pP38 levels were significantly increased, and proapoptotic factor caspase-3 activity, pERK, and pJNK levels were significantly decreased. CB1R and GluA1 levels remained unchanged; however, GluN2A was significantly reduced. There was a significant decrease in MAO activity although tyrosine hydroxylase activity was unaltered. Our study indicates that the effects of prenatal cannabinoid exposure on the cerebellum are unique compared to other brain regions by enhancing mitochondrial function and promoting neuronal survival. Further studies are required to evaluate the mechanisms by which prenatal cannabinoid exposure alters cerebellar processes and the impact of these alterations on behavior.
Keywords: Cannabinoid; Cerebellum; Developmental; Mitochondria; Oxidative stress; Prenatal exposure.
© 2021 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



































Similar articles
-
Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity.Cells. 2023 Oct 26;12(21):2525. doi: 10.3390/cells12212525. Cells. 2023. PMID: 37947603 Free PMC article.
-
Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.Neuroscience. 2011 Jan 13;172:139-52. doi: 10.1016/j.neuroscience.2010.10.031. Epub 2010 Oct 20. Neuroscience. 2011. PMID: 20969930
-
Mechanisms underlying cognitive impairment induced by prenatal cannabinoid exposure: a literature review.Eur Rev Med Pharmacol Sci. 2023 Jun;27(11):4960-4975. doi: 10.26355/eurrev_202306_32613. Eur Rev Med Pharmacol Sci. 2023. PMID: 37318470 Review.
-
Prenatal cannabinoid exposure and altered neurotransmission.Neuropharmacology. 2019 May 1;149:181-194. doi: 10.1016/j.neuropharm.2019.02.018. Epub 2019 Feb 13. Neuropharmacology. 2019. PMID: 30771373 Review.
-
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. doi: 10.1016/j.ejphar.2007.06.047. Epub 2007 Jul 4. Eur J Pharmacol. 2007. PMID: 17644084
Cited by
-
The synthetic cannabinoid 5-fluoro ABICA upregulates angiogenic markers and stimulates tube formation in human brain microvascular endothelial cells.J Taibah Univ Med Sci. 2024 Feb 1;19(2):359-371. doi: 10.1016/j.jtumed.2024.01.002. eCollection 2024 Apr. J Taibah Univ Med Sci. 2024. PMID: 38357583 Free PMC article.
-
Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.Int J Mol Sci. 2025 Jan 4;26(1):380. doi: 10.3390/ijms26010380. Int J Mol Sci. 2025. PMID: 39796234 Free PMC article. Review.
-
Impact of Intrauterine Insults on Fetal and Postnatal Cerebellar Development in Humans and Rodents.Cells. 2024 Nov 19;13(22):1911. doi: 10.3390/cells13221911. Cells. 2024. PMID: 39594658 Free PMC article. Review.
References
-
- Ahuja M., Buabeid M., Abdel-Rahman E., Majrashi M., Parameshwaran K., Amin R., Ramesh S., Thiruchelvan K., Pondugula S., Suppiramaniam V., Dhanasekaran M. Immunological alteration & toxic molecular inductions leading to cognitive impairment & neurotoxicity in transgenic mouse model of Alzheimer’s disease. Life Sci. 2017;177:49–59. - PubMed
-
- Alhowail A.H., Bloemer J., Majrashi M., Pinky P.D., Bhattacharya S., Yongli Z., Bhattacharya D., Eggert M., Woodie L., Buabeid M.A., Johnson N., Broadwater A., Smith B., Dhanasekaran M., Arnold R.D., Suppiramaniam V. Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicol. Mech. Methods. 2019;29:457–466. - PubMed
-
- Amsterdam J. van, Talhout R., Vleeming W., Opperhuizen A. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction. Life Sci. 2006 - PubMed
-
- Bailey J.R., Cunny H.C., Paule M.G., Slikker W. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol. Appl. Pharmacol. 1987;90:315–321. - PubMed
-
- Bénard G., Massa F., Puente N., Lourenço J., Bellocchio L., Soria-Gómez E., Matias I., Delamarre A., Metna-Laurent M., Cannich A., Hebert-Chatelain E., Mulle C., Ortega-Gutiérrez S., Martín-Fontecha M., Klugmann M., Guggenhuber S., Lutz B., Gertsch J., Chaouloff F., López-Rodríguez M.L., Grandes P., Rossignol R., Marsicano G. Mitochondrial CB1 receptors regulate neuronal energy metabolism. Nat. Neurosci. 2012;15:558–564. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials